LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from its phase I study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback